1. Synthesis of Novel Tetrahydroisoquinoline CXCR4 Antagonists with Rigidified Side-Chains
    Edgars Jecs et al, 2018, ACS Medicinal Chemistry Letters CrossRef
  2. A multi-targeted approach to suppress tumor-promoting inflammation
    Abbas K. Samadi et al, 2015, Seminars in Cancer Biology CrossRef
  3. Post-Translational Modifications That Drive Prostate Cancer Progression
    Ivana Samaržija, 2021, Biomolecules CrossRef
  4. [68Ga]pentixafor for CXCR4 imaging in a PC-3 prostate cancer xenograft model - comparison with [18F]FDG PET/CT, MRI and ex vivo receptor expression
    Sarah M. Schwarzenböck et al, 2017, Oncotarget CrossRef
  5. Meta-Analysis of the Relationship between CXCR4 Expression and Metastasis in Prostate Cancer
    Joo Yong Lee et al, 2014, The World Journal of Men's Health CrossRef
  6. Thromboinflammatory Processes at the Nexus of Metabolic Dysfunction and Prostate Cancer: The Emerging Role of Periprostatic Adipose Tissue
    Ibrahim AlZaim et al, 2022, Cancers CrossRef
  7. The HIF-1α/CXCR4 pathway supports hypoxia-induced metastasis of human osteosarcoma cells
    Guofeng Guan et al, 2015, Cancer Letters CrossRef
  8. NMMHC-IIA-dependent nuclear location of CXCR4 promotes migration and invasion in renal cell carcinoma
    Zhipeng Xu et al, 2016, Oncology Reports CrossRef
  9. Development and Evaluation of 1′-Acetoxychavicol Acetate (ACA)-Loaded Nanostructured Lipid Carriers for Prostate Cancer Therapy
    Bavani Subramaniam et al, 2021, Pharmaceutics CrossRef
  10. High CXC chemokine receptor 4 expression is an adverse prognostic factor in patients with clear-cell renal cell carcinoma
    H An et al, 2014, British Journal of Cancer CrossRef
  11. HPMA Copolymer CXCR4 Antagonist Conjugates Substantially Inhibited the Migration of Prostate Cancer Cells
    Zheng-Hong Peng et al, 2014, ACS Macro Letters CrossRef
  12. Multi-parametric hydrogels support 3D in vitro bioengineered microenvironment models of tumour angiogenesis
    Laura J. Bray et al, 2015, Biomaterials CrossRef
  13. N-terminal polypeptide derived from vMIP-II exerts its antitumor activity by inhibiting the CXCR4 pathway in human glioma
    Qingling Yang et al, 2017, International Journal of Oncology CrossRef
  14. Correlation between CXCR4 and MMP-2 Expression with T Stage in Clear Cell Renal Cell Carcinoma
    Pamela Kusumadewi Putri Thaib et al, 2023, Research Journal of Pharmacy and Technology CrossRef